Concepedia

R. Vickery

RV

13

Publications

574

Citations

13

H-Index

1987

Active since

Affiliations

Theravance Biopharma (United States)(Current)

R. Vickery is an author at Theravance Biopharma (United States) specializing in medicine, pharmacology, and physiology.

Top concepts

Publications per year

1987–2012

13

Publications

13

Anesthetic and Hemodynamic Effects of the Stereoisomers of Medetomidine, an ??2-Adrenergic Agonist, in Halothane-Anesthetized Dogs

R. Vickery, Brett C. Sheridan, Ira S. Segal et al. · Anesthesia & Analgesia · 1988 · 144 citations

The 5‐HT<sub>4</sub> receptor agonist, tegaserod, is a potent 5‐HT<sub>2B</sub> receptor antagonist <i>in vitro</i> and <i>in vivo</i>

David T. Beattie, Jacqueline A.M. Smith, Daniel G. Marquess et al. · British Journal of Pharmacology · 2004 · 119 citations · Full text

The in vitro pharmacological profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity

Jacqueline A.M. Smith, David T. Beattie, Daniel G. Marquess et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2008 · 58 citations

, , +9

Molecular identification of SqKv1A. A candidate for the delayed rectifier K channel in squid giant axon.

Joshua J. C. Rosenthal, R. Vickery, W. F. Gilly · The Journal of General Physiology · 1996 · 41 citations · Full text

, , +18

The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone

David T. Beattie, Madhavi Cheruvu, Ngoc Mai et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2007 · 34 citations

, , +9

Rows per page

1–5 of 13